<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02063061</url>
  </required_header>
  <id_info>
    <org_study_id>CIV-13-07-011546</org_study_id>
    <nct_id>NCT02063061</nct_id>
  </id_info>
  <brief_title>Low-energy Linear Extracorporal Shock Wave Therapy for Erectile Dysfunction.</brief_title>
  <acronym>ESWTvsED</acronym>
  <official_title>Low-energy Linear Extracorporal Shock Wave Therapy for Erectile Dysfunction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grzegorz Fojecki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether extracorporeal shock wave therapy (ESWT) is
      an effective treatment for erectile dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Erectile dysfunction has a negative impact on quality of life and relationships. Thirty to
      sixty- five percent of men over 40 years of age have erection disorders. Current challenges
      of medical treatment are met with high costs and risks of side effects. Emerging new therapy
      with low-energy shock waves stimulate production of endothelial growth factor and nitrogen
      oxide which results in angiogenesis. It is our aim to assess efficaciousness of this method
      on potential to improve erectile dysfunction. We propose a prospective double-blind,
      randomised, cross-over, sham-controlled trial, to assess how effective shock waves therapy is
      for erectile dysfunction. Patients will receive one treatment per week for ten weeks.
      Subjects will be followed for up to one year after treatment. Standardized questionnaires
      will assess study endpoints for erectile dysfunction. We hypothesize that shock wave therapy
      could represent a low cost, low risk treatment for erectile dysfunction in men.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Index of Erectile Function (IIEF) outcome increases by 5 points</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Erectile Hardness Scale (EHS) outcome is equal or higher than 3.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) outcome</measure>
    <time_frame>18 weeks</time_frame>
    <description>Assesed after complition af clinical trial</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>18 weeks</time_frame>
    <description>During treatment period all patients will be examined for advers events</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Sham treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subject will answer standardized questionnaires. Sham treatment arm will receive initially 5 sham series and after they answer standardized questionnaires they will receive 5 series of active treatment. Afterwards patients will answer standardized questionnaires again.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESWT treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will answer standardized questionnaires. Subjects will receive 10 treatments with ESWT. Afterwards patients will answer standardized questionnaires again.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham treatment</intervention_name>
    <description>Patients will receive simulated treatment, with the same ESWT unit as in other arm. Placebo gel-pad is design to prevent shockwaves emission. Looks identical as active gel-pad.</description>
    <arm_group_label>Sham treatment</arm_group_label>
    <other_name>Sham</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ESWT treatment</intervention_name>
    <description>ESWT treatment group will receive 600 low-energy, linear shockwaves against erectile dysfunction per week in 10 weeks.</description>
    <arm_group_label>Sham treatment</arm_group_label>
    <arm_group_label>ESWT treatment</arm_group_label>
    <other_name>ESWT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Erectile dysfunction for at least 6 months

          -  In relationships

          -  Patient accept not to use any other therapy against erectile dysfunction

        Exclusion Criteria:

          -  Prostatectomy

          -  Radiotherapy in pelvis

          -  Hormonal therapy against prostate cancer

          -  Anatomical penis disorder

          -  Penile prosthesis

          -  Treatment with anticoagulants (except acetylsalicylic acid 75 mg)

          -  Psychiatric disorder

          -  Hypogonadism

          -  IIEF score higher than 25

          -  Pregnant partner og delivered within last 12 months

          -  Critical health disease

          -  Neurological disorders
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Palle Oshter, professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Southern Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of Southern Denmark</name>
      <address>
        <city>Sonderborg</city>
        <state>Southern Denmark</state>
        <zip>6400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://komite.regionsyddanmark.dk/wm258128</url>
    <description>regional ethical committee</description>
  </link>
  <link>
    <url>http://www.sdu.dk/</url>
    <description>University of Southern Denmark</description>
  </link>
  <results_reference>
    <citation>Gruenwald I, Appel B, Kitrey ND, Vardi Y. Shockwave treatment of erectile dysfunction. Ther Adv Urol. 2013 Apr;5(2):95-9. doi: 10.1177/1756287212470696.</citation>
    <PMID>23554844</PMID>
  </results_reference>
  <results_reference>
    <citation>Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012 Jan;9(1):259-64. doi: 10.1111/j.1743-6109.2011.02498.x. Epub 2011 Oct 18.</citation>
    <PMID>22008059</PMID>
  </results_reference>
  <results_reference>
    <citation>Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010 Aug;58(2):243-8. doi: 10.1016/j.eururo.2010.04.004. Epub 2010 May 6.</citation>
    <PMID>20451317</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2014</study_first_posted>
  <last_update_submitted>December 23, 2016</last_update_submitted>
  <last_update_submitted_qc>December 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern Denmark</investigator_affiliation>
    <investigator_full_name>Grzegorz Fojecki</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>extracorporeal shock wave therapy ESWT</keyword>
  <keyword>erectile dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

